Beta 2-agonists in asthma.

Beta 2-agonists in asthma.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Britton, J, Pavord, I, Wong, C, Tattersfields, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	1991

Παρόμοια τεκμήρια

β2-agonists in asthma
ανά: Britton, J, κ.ά.
Έκδοση: (1991)

Asthma control during and after cessation of regular beta 2-agonist treatment.
ανά: Wahedna, I, κ.ά.
Έκδοση: (1993)

Use of long-acting beta2 agonists in arginine-16 homozygous patients with asthma.
ανά: Green, R, κ.ά.
Έκδοση: (2008)

Beta2-Agonists and Asthma in Children
ανά: Guy Lapierre
Έκδοση: (1995-01-01)

Beta-Adrenergic Receptors and Mechanisms in Asthma: The New Long-Acting Beta-Agonists
ανά: Robert G Townley
Έκδοση: (1996-01-01)

Canadian Thoracic Society Asthma Committee Commentary on Long-Acting Beta-2 Agonist Use for Asthma in Canada
ανά: M Diane Lougheed, κ.ά.
Έκδοση: (2010-01-01)

Effect of 443c81, an inhaled mu-opioid receptor agonist in asthma.
ανά: Pavord, I, κ.ά.
Έκδοση: (1994)

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma.
ανά: Wong, C, κ.ά.
Έκδοση: (1990)

Should ipratropium bromide be added to beta-agonists in treatment of acute severe asthma?
ανά: Higgins, R, κ.ά.
Έκδοση: (1988)

What Is the Role of Beta-Agonist Bronchodilators in the Day-to-Day Treatment of Chronic Asthma?
ανά: Pierre Ernst
Έκδοση: (1995-01-01)

The Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study
ανά: Rishi Jayant Khusial, κ.ά.
Έκδοση: (2024-12-01)

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
ανά: Crossingham, I, κ.ά.
Έκδοση: (2020)

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists
ανά: Willson, J, κ.ά.
Έκδοση: (2014)

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists.
ανά: Willson, J, κ.ά.
Έκδοση: (2014)

The Relationship among the Inspiratory Muscle Strength, the Perception of Dyspnea and Inhaled Beta2-Agonists in Patients with Asthma
ανά: Paltiel Weiner, κ.ά.
Έκδοση: (2002-01-01)

Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
ανά: Crossingham, I, κ.ά.
Έκδοση: (2021)

Effect of inhaled prostaglandin E2 on allergen-induced asthma.
ανά: Pavord, I, κ.ά.
Έκδοση: (1993)

Loss of Asthma Control in Pediatric Patients after Discontinuation of Long-Acting Beta-Agonists
ανά: Adrian R. O'Hagan, κ.ά.
Έκδοση: (2012-01-01)

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
ανά: Pavord, I, κ.ά.
Έκδοση: (2017)

Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation
ανά: Kulalert P, κ.ά.
Έκδοση: (2020-08-01)

Beta-2 agonists for the treatment of bronchiolitis
ανά: Constanza Gómez, κ.ά.
Έκδοση: (2020-09-01)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
ανά: Lee SY, κ.ά.
Έκδοση: (2016-11-01)

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany
ανά: Heinrich Worth, κ.ά.
Έκδοση: (2021-04-01)

Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation
ανά: van der Burg NMD, κ.ά.
Έκδοση: (2024-01-01)

Beta-Adrenergic Agonists
ανά: Giovanni Barisione, κ.ά.
Έκδοση: (2010-03-01)

Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia
ανά: Chin, M.C., κ.ά.
Έκδοση: (2017)

Use of beta-2 agonists and risk of hip fracture
ανά: De Vries, F, κ.ά.
Έκδοση: (2006)

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma
ανά: Leanne Kaye, κ.ά.
Έκδοση: (2022-09-01)

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD
ανά: Scichilone N, κ.ά.
Έκδοση: (2014-11-01)

Asthma phenotypes.
ανά: Pavord, I
Έκδοση: (2012)

Cough and asthma.
ανά: Pavord, I
Έκδοση: (2004)

β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
ανά: Paakinaho A, κ.ά.
Έκδοση: (2023-06-01)

New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
ανά: Koshak Emad
Έκδοση: (2010-01-01)

The role of polymorphic variants of arginase genes (<i>ARG1, ARG2</i>) involved in beta-2-agonist metabolism in the development and course of asthma
ανά: O. N. Savelieva, κ.ά.
Έκδοση: (2020-07-01)

A severe tremor caused by a beta2 agonist in a patient with asthma‐chronic obstructive pulmonary disease overlap
ανά: Kota Nakajima, κ.ά.
Έκδοση: (2024-08-01)

Impulse Oscillometry; Therapeutic Impacts of Transdermal Long-Acting Beta-2 Agonist Patch in Elderly Asthma with Inhaled Corticosteroid Alone
ανά: Hiroshi Tanaka, κ.ά.
Έκδοση: (2012-01-01)

Asthma as a nonlinear complex dynamic system: a novel approach to understand the temporal behaviour of chronic asthma and its response to beta-agonists
ανά: Urs Frey
Έκδοση: (2008-06-01)

The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study
ανά: Liselot N van den Berg, κ.ά.
Έκδοση: (2024-04-01)

Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β2-agonists in patients with atopic asthma
ανά: Bateman ED, κ.ά.
Έκδοση: (2018-05-01)

Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia
ανά: Hao-Chien Wang, MD PhD, κ.ά.
Έκδοση: (2023-10-01)